AI assistant
Sending…
BIODESIX INC — Director's Dealing 2022
Mar 14, 2022
34472_dirs_2022-03-14_75987588-3cd7-4467-a356-bca05757be9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-03-10
Reporting Person: Georgantas Robert William III (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-10 | Stock Options (Right to buy) | $2.29 | A | 22722 | Acquired | 2032-03-09 | Common Stock (22722) | Direct |
More from BIODESIX INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23